featured-Reporter

Zach Lloyd spent 95 days on extracorporeal membrane oxygenation, or ECMO, after contracting COVID-19.

COVID recovery included long stay on ECMO, double-lung transplant

Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.

Deanna Edwards, PhD, left, Jin Chen, MD, PhD, and colleagues are studying a new therapeutic strategy for triple-negative breast cancer.

Breast cancer cells ‘steal’ nutrients from immune cells: study

Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered.

Study shows new COVID target could improve vaccines

Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus.

The teen cancer lounge’s main area offers video games, a big screen television, a selection of movies and streaming capabilities for favorite televisions shows, a Wi-Fi connection, and space to interact with peers.

Teen cancer lounge at Monroe Carell Jr. Children’s Hospital at Vanderbilt unveiled

Monroe Carell Jr. Children’s Hospital at Vanderbilt and Teen Cancer America announced March 31 the completion of a new state-of-the-art lounge to serve the unique needs of adolescent and young adult (AYA) cancer patients.

After a brachial plexus injury caused Delvonte Mayberry, right, to lose use of his right arm, Mihir Desai, MD, performed a complex reconstruction of the nerve network.

VUMC is regional center of care for treating rare brachial plexus injuries

Delvonte Mayberry was riding his motorcycle in his hometown of Clarksville, Tennessee, when a motorist pulled in front of him, sending him flipping over the vehicle. Mayberry was airlifted in critical condition to Vanderbilt University Medical Center via LifeFlight.

Allison Norlander, PhD, R. Stokes Peebles, MD, and colleagues are studying an approved drug that enhances immune cells and might be useful for treating inflammatory and autoimmune diseases.

Team studies new use for pulmonary hypertension drug

An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.

1 27 28 29 30 31 161